Cvs Health Corporation (CVS)
NYSE: CVS · Retail-Drug Stores and Proprietary Stores · Woonsocket, RI · filing with the SEC since 1994
Grade5.6
◀ Past 5.5● Present 6.0▶ Future 5.1
Filings
486 filings since 2017 beside 655 insider forms · Large accelerated filer · read from EDGAR on Nov 13, 2026Due nextLarge accelerated filer
10-K
Annual report for the fiscal year ending Dec 31, 2026Large accelerated filers have 60 days after the fiscal year ends.
by Mar 1, 2027
10-Q
Quarterly report for the quarter ending Mar 31, 2027Large accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end.
by May 10, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 35 days after the quarter ended. The proxy statement was last filed Apr 3, 2026.
Filings a yearinsider forms included
1091271001141171118462
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 9 times in the last 36 months, the newest Aug 17, 2026.SEC letters: 3 in the last 36 months, the newest Nov 21, 2024.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Aug 17, 2026
8-K items 5.02, 7.01, 9.01
Officer or director change; Investor disclosure (Regulation FD) · Current reportThe SI's read CVS Health reports that board member Larry Robbins resigned for reasons unrelated to any disagreement with the company, and the board appointed Teresa Heitsenrether, a senior JPMorgan Chase executive, as a new independent director starting November 2026. This is a routine board membership change with no impact on operations, money, or strategy.
Aug 13, 2026
Aug 5, 2026
10-Q
Quarterly reportThe SI's read CVS renewed and updated its main revolving credit line with a group of banks, moving the size to 2.5 billion dollars and pushing the end date out to May 2030. This is routine refinancing of an existing backup credit facility, not new borrowing, so it does not change CVS's current debt load or spending.
Jun 30, 2026
Aug 5, 2026
8-K items 2.02, 9.01
Results released · Current reportThe SI's read CVS Health filed a routine notice announcing it released its second quarter 2026 financial results in a press release attached to the filing. The 8-K itself contains no numbers, only the cover paperwork pointing to the actual earnings release exhibit, so there is nothing here to judge the business by.
May 18, 2026
8-K items 5.02, 5.07
Officer or director change; Shareholder vote · Current report
May 14, 2026
40 of 486 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.